Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
2 "Wearable electronic devices"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Reviews
Technology/Device
Article image
Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence
Sun Joon Moon, Inha Jung, Cheol-Young Park
Diabetes Metab J. 2021;45(6):813-839.   Published online November 22, 2021
DOI: https://doi.org/10.4093/dmj.2021.0177
  • 15,118 View
  • 831 Download
  • 32 Web of Science
  • 32 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Since Banting and Best isolated insulin in the 1920s, dramatic progress has been made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely injection to maintain optimal glycemic control are often challenging for T1DM patients and their families because they require frequent blood glucose checks. In recent years, technological advances in insulin pumps and continuous glucose monitoring systems have created paradigm shifts in T1DM care that are being extended to develop artificial pancreas systems (APSs). Numerous studies that demonstrate the superiority of glycemic control offered by APSs over those offered by conventional treatment are still being published, and rapid commercialization and use in actual practice have already begun. Given this rapid development, keeping up with the latest knowledge in an organized way is confusing for both patients and medical staff. Herein, we explore the history, clinical evidence, and current state of APSs, focusing on various development groups and the commercialization status. We also discuss APS development in groups outside the usual T1DM patients and the administration of adjunct agents, such as amylin analogues, in APSs.

Citations

Citations to this article as recorded by  
  • The effects of acute hyperglycaemia on sports and exercise performance in type 1 diabetes: A systematic review and meta-analysis
    Bonar McGuire, Hashim Dadah, Dominic Oliver
    Journal of Science and Medicine in Sport.2024; 27(2): 78.     CrossRef
  • A new approach to stabilize diabetes systems with time-varying delays and disturbance rejection
    S. Syafiie, Fahd Alharbi, Abdullah Ali Alshehri, Bassam Hasanain
    Journal of the Franklin Institute.2024; 361(1): 543.     CrossRef
  • Effects of Low-Dose Glucagon on Subcutaneous Insulin Absorption in Pigs
    Ingrid Anna Teigen, Marte Kierulf Åm, Misbah Riaz, Sverre Christian Christiansen, Sven Magnus Carlsen
    Current Therapeutic Research.2024; 100: 100736.     CrossRef
  • Enhancing equity in access to automated insulin delivery systems in an ethnically and socioeconomically diverse group of children with type 1 diabetes
    John Pemberton, Louise Collins, Lesley Drummond, Renuka P Dias, Ruth Krone, Melanie Kershaw, Suma Uday
    BMJ Open Diabetes Research & Care.2024; 12(3): e004045.     CrossRef
  • Robust Online Correlation Method for Identification of a Nonparametric Model of Type 1 Diabetes
    Martin Dodek, Eva Miklovičová
    IEEE Access.2024; 12: 35899.     CrossRef
  • Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial
    Ji Yoon Kim, Sang-Man Jin, Eun Seok Kang, Soo Heon Kwak, Yeoree Yang, Jee Hee Yoo, Jae Hyun Bae, Jun Sung Moon, Chang Hee Jung, Ji Cheol Bae, Sunghwan Suh, Sun Joon Moon, Sun Ok Song, Suk Chon, Jae Hyeon Kim
    Diabetologia.2024; 67(7): 1235.     CrossRef
  • Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways
    Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Maria Luisa Garo, Donatella Pastore, Francesca Pacifici, Camillo Ricordi, David Della-Morte, Marco Infante
    Metabolism and Target Organ Damage.2024;[Epub]     CrossRef
  • Mitigating diabetes associated with reactive oxygen species (ROS) and protein aggregation through pharmacological interventions
    Giulia Bennici, Hanan Almahasheer, Mawadda Alghrably, Daniela Valensin, Arian Kola, Chrysoula Kokotidou, Joanna Lachowicz, Mariusz Jaremko
    RSC Advances.2024; 14(25): 17448.     CrossRef
  • 100 Years of insulin: A chemical engineering perspective
    B. Wayne Bequette
    Korean Journal of Chemical Engineering.2023; 40(1): 1.     CrossRef
  • Efficacy of intermittent short‐term use of a real‐time continuous glucose monitoring system in non‐insulin–treated patients with type 2 diabetes: A randomized controlled trial
    Sun Joon Moon, Kyung‐Soo Kim, Woo Je Lee, Mi Yeon Lee, Robert Vigersky, Cheol‐Young Park
    Diabetes, Obesity and Metabolism.2023; 25(1): 110.     CrossRef
  • Identifiable prediction animal model for the bi-hormonal intraperitoneal artificial pancreas
    Karim Davari Benam, Hasti Khoshamadi, Marte Kierulf Åm, Øyvind Stavdahl, Sebastien Gros, Anders Lyngvi Fougner
    Journal of Process Control.2023; 121: 13.     CrossRef
  • Advances in Continuous Glucose Monitoring and Integrated Devices for Management of Diabetes with Insulin-Based Therapy: Improvement in Glycemic Control
    Jee Hee Yoo, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2023; 47(1): 27.     CrossRef
  • CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review
    John S Pemberton, Emma G Wilmot, Katharine Barnard‐Kelly, Lalantha Leelarathna, Nick Oliver, Tabitha Randell, Craig E Taplin, Pratik Choudhary, Peter Adolfsson
    Diabetes, Obesity and Metabolism.2023; 25(4): 916.     CrossRef
  • Evaluation of awareness and attitude of paediatric nursing students, nurses, and adolescents regarding type one diabetes advanced devices and virtual nursing
    Howaida Moawad Ahmed Ali
    Kontakt.2023; 25(2): 100.     CrossRef
  • Predicting the output error of the suboptimal state estimator to improve the performance of the MPC-based artificial pancreas
    Martin Dodek, Eva Miklovičová
    Control Theory and Technology.2023; 21(4): 541.     CrossRef
  • A Markov Model of Gap Occurrence in Continuous Glucose Monitoring Data for Realistic in Silico Clinical Trials
    Martina Vettoretti, Martina Drecogna, Simone Del Favero, Andrea Facchinetti, Giovanni Sparacino
    Computer Methods and Programs in Biomedicine.2023; 240: 107700.     CrossRef
  • Drug delivery breakthrough technologies – A perspective on clinical and societal impact
    Beate Bittner, Manuel Sánchez-Félix, Dennis Lee, Athanas Koynov, Joshua Horvath, Felix Schumacher, Simon Matoori
    Journal of Controlled Release.2023; 360: 335.     CrossRef
  • Importance of continuous glucose monitoring in the treatment of diabetes mellitus
    Sun Joon Moon, Won-Young Lee
    Journal of the Korean Medical Association.2023; 66(7): 432.     CrossRef
  • Constrained Versus Unconstrained Model Predictive Control for Artificial Pancreas
    Chiara Toffanin, Lalo Magni
    IEEE Transactions on Control Systems Technology.2023; 31(5): 2288.     CrossRef
  • Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?
    Valentina Maria Cambuli, Marco Giorgio Baroni
    International Journal of Molecular Sciences.2023; 24(17): 13139.     CrossRef
  • Artificial Intelligence in Efficient Diabetes Care
    Gopal Bhagwan Khodve, Sugato Banerjee
    Current Diabetes Reviews.2023;[Epub]     CrossRef
  • The artificial pancreas: two alternative approaches to achieve a fully closed-loop system with optimal glucose control
    M. K. Åm, I. A. Teigen, M. Riaz, A. L. Fougner, S. C. Christiansen, S. M. Carlsen
    Journal of Endocrinological Investigation.2023; 47(3): 513.     CrossRef
  • Multivariable Automated Insulin Delivery System for Handling Planned and Spontaneous Physical Activities
    Mohammad Reza Askari, Mohammad Ahmadasas, Andrew Shahidehpour, Mudassir Rashid, Laurie Quinn, Minsun Park, Ali Cinar
    Journal of Diabetes Science and Technology.2023; 17(6): 1456.     CrossRef
  • Advanced Technology (Continuous Glucose Monitoring and Advanced Hybrid Closed-Loop Systems) in Diabetes from the Perspective of Gender Differences
    Maria Grazia Nuzzo, Marciano Schettino
    Diabetology.2023; 4(4): 519.     CrossRef
  • Integration of a Safety Module to Prevent Rebound Hypoglycemia in Closed-Loop Artificial Pancreas Systems
    María F. Villa-Tamayo, Patricio Colmegna, Marc D. Breton
    Journal of Diabetes Science and Technology.2023;[Epub]     CrossRef
  • Artificial Pancreas under a Zone Model Predictive Control based on Gaussian Process models: toward the personalization of the closed loop
    Marco Polver, Beatrice Sonzogni, Mirko Mazzoleni, Fabio Previdi, Antonio Ferramosca
    IFAC-PapersOnLine.2023; 56(2): 9642.     CrossRef
  • Personalized Constrained MPC for glucose regulation
    Chiara Toffanin, Lalo Magni
    IFAC-PapersOnLine.2023; 56(2): 9648.     CrossRef
  • Automated Insulin Delivery Systems in Children and Adolescents With Type 1 Diabetes: A Systematic Review and Meta-analysis of Outpatient Randomized Controlled Trials
    Baoqi Zeng, Le Gao, Qingqing Yang, Hao Jia, Feng Sun
    Diabetes Care.2023; 46(12): 2300.     CrossRef
  • Novel Glycemic Index Based on Continuous Glucose Monitoring to Predict Poor Clinical Outcomes in Critically Ill Patients: A Pilot Study
    Eun Yeong Ha, Seung Min Chung, Il Rae Park, Yin Young Lee, Eun Young Choi, Jun Sung Moon
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Dual‐hormone artificial pancreas for glucose control in type 1 diabetes: A meta‐analysis
    Baoqi Zeng, Hao Jia, Le Gao, Qingqing Yang, Kai Yu, Feng Sun
    Diabetes, Obesity and Metabolism.2022; 24(10): 1967.     CrossRef
  • Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Systematic Review
    Alezandra Torres-Castaño, Amado Rivero-Santana, Lilisbeth Perestelo-Pérez, Andrea Duarte-Díaz, Analia Abt-Sacks, Vanesa Ramos-García, Yolanda Álvarez-Pérez, Ana M. Wäagner, Mercedes Rigla, Pedro Serrano-Aguilar
    Applied Sciences.2022; 12(20): 10262.     CrossRef
  • History of insulin treatment of pediatric patients with diabetes in Korea
    Jae Hyun Kim, Choong Ho Shin, Sei Won Yang
    Annals of Pediatric Endocrinology & Metabolism.2021; 26(4): 237.     CrossRef
Technology/Device
Article image
Present and Future of Digital Health in Diabetes and Metabolic Disease
Sang Youl Rhee, Chiweon Kim, Dong Wook Shin, Steven R. Steinhubl
Diabetes Metab J. 2020;44(6):819-827.   Published online December 23, 2020
DOI: https://doi.org/10.4093/dmj.2020.0088
  • 9,550 View
  • 275 Download
  • 20 Web of Science
  • 21 Crossref
AbstractAbstract PDFPubReader   ePub   
The use of information and communication technology (ICT) in medical and healthcare services goes beyond everyday life. Expectations of a new medical environment, not previously experienced by ICT, exist in the near future. In particular, chronic metabolic diseases such as diabetes and obesity, have a high prevalence and high social and economic burden. In addition, the continuous evaluation and monitoring of daily life is important for effective treatment and management. Therefore, the wide use of ICTbased digital health systems is required for the treatment and management of these diseases. In this article, we compiled a variety of digital health technologies introduced to date in the field of diabetes and metabolic diseases.

Citations

Citations to this article as recorded by  
  • Digital Health in Diabetes and Cardiovascular Disease
    Dorothy Avoke, Abdallah Elshafeey, Robert Weinstein, Chang H. Kim, Seth S. Martin
    Endocrine Research.2024; : 1.     CrossRef
  • Weight Management Health Note, a Mobile Health Platform for Obesity Management Developed by the Korean Society for the Study of Obesity
    Yujung Lee, Hyunji Sang, Sunyoung Kim, Doo Ah Choi, Sang Youl Rhee
    Journal of Obesity & Metabolic Syndrome.2024; 33(1): 1.     CrossRef
  • Effectiveness of a Social Networking Site Based Automatic Mobile Message Providing System on Glycemic Control in Patients with Type 2 Diabetes Mellitus
    Kyuho Kim, Jae-Seung Yun, Joonyub Lee, Yeoree Yang, Minhan Lee, Yu-Bae Ahn, Jae Hyoung Cho, Seung-Hyun Ko
    Endocrinology and Metabolism.2024; 39(2): 344.     CrossRef
  • A data-driven approach to manage type 2 diabetes mellitus through digital health: The Klivo Intervention Program protocol (KIPDM)
    Camila Maciel de Oliveira, Luiza Borcony Bolognese, Mercedes Balcells, Davi Casale Aragon, Roberto Luis Zagury, Clemente Nobrega, Chunyu Liu, Dured Dardari
    PLOS ONE.2023; 18(2): e0281844.     CrossRef
  • Public Health Framework for Smart Cities within the Comprehensive Approach to Sustainability in Europe: Case Study of Diabetes
    Luís Velez Lapão, Jorge César Correia, Marija Jevtic
    Sustainability.2023; 15(5): 4269.     CrossRef
  • Lessons for Vietnam on the Use of Digital Technologies to Support Patient-Centered Care in Low- and Middle-Income Countries in the Asia-Pacific Region: Scoping Review
    Leona Kosowicz, Kham Tran, Toan Tran Khanh, Thu Ha Dang, Van An Pham, Hue Ta Thi Kim, Hoang Thi Bach Duong, Tran Dong Nguyen, Anh Tuyet Phuong, Trong Hieu Le, Van Anh Ta, Nilmini Wickramasinghe, Penelope Schofield, John Zelcer, Tuan Pham Le, Tuan Anh Nguy
    Journal of Medical Internet Research.2023; 25: e43224.     CrossRef
  • Digital health, cardiometabolic disease and ethnicity: an analysis of United Kingdom government policies from 2010 to 2022
    Zareen Thorlu-Bangura, Lydia Poole, Harpreet Sood, Nushrat Khan, Fiona Stevenson, Kamlesh Khunti, Paramjit Gill, Madiha Sajid, Wasim Hanif, Neeraj Bhala, Shivali Modha, Kiran Patel, Ann Blandford, Amitava Banerjee, Mel Ramasawmy
    Journal of Public Health Policy.2023; 44(2): 179.     CrossRef
  • Digital Behavior Change Interventions to Reduce Sedentary Behavior and Promote Physical Activity in Adults with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Xiaoyan Zhang, Xue Qiao, Ke Peng, Shan Gao, Yufang Hao
    International Journal of Behavioral Medicine.2023;[Epub]     CrossRef
  • Exploring the underlying mechanisms of obesity and diabetes and the potential of Traditional Chinese Medicine: an overview of the literature
    Yan-kun Chen, Ting-ting Liu, Farah Khameis Farag Teia, Meng-zhou Xie
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Stakeholders’ Perceptions Regarding Digital Therapeutics Reimbursement in South Korea: Qualitative Study
    Boram Sim, Jin Han Ju, Byungsoo Kim, Jin Yong Lee
    JMIR mHealth and uHealth.2023; 11: e47407.     CrossRef
  • Research Trends in Motivation and Weight Loss: A Bibliometric-Based Review
    Uroš Železnik, Peter Kokol, Jasmina Starc, Danica Železnik, Jernej Završnik, Helena Blažun Vošner
    Healthcare.2023; 11(23): 3086.     CrossRef
  • Analysis of the management and therapeutic performance of diabetes mellitus employing special target
    Hong-Yan Sun, Xiao-Yan Lin
    World Journal of Diabetes.2023; 14(12): 1721.     CrossRef
  • Psychoeducational Interventions in Children and Adolescents with Type-1 Diabetes: A Systematic Review
    Bárbara Luque, Joaquín Villaécija, Rosario Castillo-Mayén, Esther Cuadrado, Sebastián Rubio, Carmen Tabernero
    Clínica y Salud.2022; 33(1): 35.     CrossRef
  • Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015–16 and 2018–19
    Mei Zhang, Xiaoxia Zhu, Jing Wu, Zhengjing Huang, Zhenping Zhao, Xiao Zhang, Yu Xue, Weiguo Wan, Chun Li, Wenrong Zhang, Linhong Wang, Maigeng Zhou, Hejian Zou, Limin Wang
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Blood Pressure Monitoring as a Digital Health Tool for Improving Diabetes Clinical Outcomes: Retrospective Real-world Study
    ‪Yifat Fundoiano-Hershcovitz, Dror Bacher, Marilyn D Ritholz, David L Horwitz, Omar Manejwala, Pavel Goldstein
    Journal of Medical Internet Research.2022; 24(2): e32923.     CrossRef
  • The effectiveness of a structured group education programme for people with established type 2 diabetes in a multi-ethnic population in primary care: A cluster randomised trial
    Helen Dallosso, Panna Mandalia, Laura J. Gray, Yogini V. Chudasama, Sopna Choudhury, Shahrad Taheri, Naina Patel, Kamlesh Khunti, Melanie J. Davies
    Nutrition, Metabolism and Cardiovascular Diseases.2022; 32(6): 1549.     CrossRef
  • Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record–Integrated Mobile App in Patients With Type 2 Diabetes: 6-Month Randomized Controlled Trial
    Eun Young Lee, Seon-Ah Cha, Jae-Seung Yun, Sun-Young Lim, Jin-Hee Lee, Yu-Bae Ahn, Kun-Ho Yoon, Min Kyung Hyun, Seung-Hyun Ko
    Journal of Medical Internet Research.2022; 24(7): e37430.     CrossRef
  • Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus—a study protocol
    Noor Suleiman, Meis Alkasem, Zaina Al Amer, Obada Salameh, Noora Al-Thani, Mohammad Khair Hamad, Khaled Baagar, Ibrahem Abdalhakam, Manal Othman, Ragae Dughmosh, Dabia Al-Mohanadi, Ali Al Sanousi, Mohammed Bashir, Odette Chagoury, Shahrad Taheri, Abdul-Ba
    Trials.2022;[Epub]     CrossRef
  • Digital environment: An evolutionary component in environmental health
    Afiqah Syamimi Masrani, Nik Rosmawati Nik Husain
    Journal of Public Health Research.2022; 11(2): 227990362211031.     CrossRef
  • Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic
    Lavanya Kondapalli, Garima Arora, Riem Hawi, Efstathia Andrikopoulou, Courtney Estes, Nirav Patel, Carrie G. Lenneman
    Current Treatment Options in Oncology.2022; 23(9): 1288.     CrossRef
  • Effects of peer support and mobile application-based walking programme on physical activity and physical function in rural older adults: a cluster randomized controlled trial
    Xue Cai, Shanhu Qiu, Dan Luo, Ruxue Li, Chengyu Liu, Yanhui Lu, Cuirong Xu, Mingzi Li
    European Geriatric Medicine.2022; 13(5): 1187.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer